San Diego, United States
DERMALA Inc., founded in 2014, is a forward-thinking startup at the intersection of Biotechnology and Health Care, with headquarters in the United States. The company is transforming consumer dermatology by utilizing the human microbiome and advanced data analytics to create novel, science-based treatments. Their products aim to combat skin conditions like acne and eczema, enhancing skin health and longevity.
Guided by the slogan, "Backed by science. Clinically tested. Fighting acne from the inside and outside," DERMALA emphasizes its commitment to scientific innovation and clinical validation. The company recently secured a $4.50M Series A investment on 09 November 2020, backed by prominent investors including True Wealth Ventures, Seventure Partners, The Cove Fund, and Johnson & Johnson Robotics and Digital Solutions. This investment underlines its potential to disrupt the dermatology market through revolutionary, data-driven skincare solutions.
